| Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
|---|---|---|---|---|---|
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 1331 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 2958 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 4349 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 8540 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 9526 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 9981 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 10329 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 10853 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 12004 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 13811 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 15353 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 16710 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 16805 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 17184 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 17225 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 17626 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 17692 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 17821 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18016 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18106 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18159 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18307 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18635 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18955 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 18980 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 19082 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 19132 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 19869 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 20931 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 21422 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 22094 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 22111 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 22168 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 22631 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 22782 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 22955 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 23089 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 23371 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 23763 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 23801 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 24031 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 24438 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 24637 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 24757 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 24849 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 25045 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 25115 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 25510 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 25528 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 25765 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 25766 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26089 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26186 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26307 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26311 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26523 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26605 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 26769 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27141 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27304 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27445 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27543 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27548 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27657 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27690 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27697 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27761 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27762 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 27782 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 28206 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 28539 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 28819 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 28868 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 28949 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 29166 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 29363 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 29371 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 29461 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 29755 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 29919 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30033 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30093 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30154 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30176 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30357 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30411 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30419 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30420 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30454 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30567 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30588 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30595 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30661 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30668 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30761 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30762 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30765 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30802 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30818 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30819 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30896 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 30927 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31000 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31011 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31018 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31029 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31047 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31059 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31065 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31120 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31145 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31175 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31208 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31213 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31257 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31323 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31368 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31393 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31492 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31608 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31654 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31738 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31768 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 31835 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 32050 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 32143 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 32181 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 32238 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 32377 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 32424 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33078 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33111 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33182 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33228 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33327 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33341 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33665 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 33817 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 34319 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 34488 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 34746 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 34800 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 34885 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 34957 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35095 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35118 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35120 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35239 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35476 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35550 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35624 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35837 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 35865 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36144 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36346 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36485 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36624 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36809 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36928 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 36949 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 37061 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 37591 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 37658 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 37959 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 38442 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 38683 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 38841 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 38994 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 39076 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 39377 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 39597 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 39789 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 39799 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 40093 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 40549 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 40585 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 41088 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 41130 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 41131 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 41312 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 42231 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 42294 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 42694 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 43347 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 43451 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 43454 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 43661 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 43729 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 44038 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 44112 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 44465 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 44594 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 44770 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 45647 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 45833 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 45973 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 46197 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 47004 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 47312 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | sphinganine (C18) | 47553 | Peak area normalized | red cross plasma | - |
Return to search page
